LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth von Liu, Ling, Zeng, Wei, Wortinger, Mark A, Yan, S Betty, Cornwell, Paul, Peek, Victoria L, Stephens, Jennifer R, Tetreault, Jonathan W, Xia, Jinqi, Manro, Jason R, Credille, Kelly M, Ballard, Darryl W, Brown-Augsburger, Patricia, Wacheck, Volker, Chow, Chi-Kin, Huang, Lihua, Wang, Yong, Denning, Irene, Davies, Julian, Tang, Ying, Vaillancourt, Peter, Lu, Jirong

Volltext

Initial biological qualification of SBDP-145 as a biomarker of compound-induced neurodegeneration in the rat von Pritt, Michael L, Hall, D Greg, Jordan, William H, Ballard, Darryl W, Wang, Kevin K W, Müller, Uwe R, Watson, David E

Volltext

New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated) von Macias, William L, Yan, S Betty, Williams, Mark D, Um, Suzane L, Sandusky, George E, Ballard, Darryl W, Planquois, Jean-Michel S

Volltext

Abstract 4403: Preclinical evaluation of LY2801653, an orally bioavailable small molecule oncokinase inhibitor, in cholangiocarcinoma models von Yan, Sau-Chi Betty, Um, Suzane L., Peek, Victoria L., Thobe, Megan N., Credille, Kelly M., Stephens, Jennifer R., Manro, Jason R., Ballard, Darryl W., Baker, Jessica A., Cook, Joel D., Konicek, Bruce W., Graff, Jeremy R., Holzer, Timothy R., Walgren, Richard A.

Volltext

Abstract 2087: Detection of KRAS mutations in circulating tumor cells (CTCs) and in formalin-fixed, paraffin-embedded (FFPE) tissue using castPCR method von Thobe, Megan N., Um, Suzane L., Peek, Victoria L., Ballard, Darryl W., Konicek, Bruce W., Credille, Kelly M., Ebert, Philip J., Donoho, Gregory P., Yan, S. Betty

Volltext

Abstract 2339: Prevalence of MET expression, activating mutations of KRAS and IDH1/2, and ROS1 fusions in cholangiocarcinoma patient tumor samples von Thobe, Megan N., Yan, S. Betty, Credille, Kelly M., Nasir, Aejaz, Roseberry Baker, Jessica A., Lajiness, Mary, Brooks, Nathan A., Ballard, Darryl W., Farley, Donna M., Peek, Victoria L., Um, Suzane L., Jin, G. Jason, Gilmour, Raymond, Reinhard, Christoph, Graff, Jeremy R., Schade, Andrew E., Gruver, Aaron M., Colligan, Bruce, Douglass, Larry, Carter, Julia, Walgren, Richard A.

Volltext

Abstract B31: Potential for patient tailoring for prodrug of gemcitabine (LY2334737) by assessment carboxylesterase II expression in solid tumor biopsies von Holzer, Timothy R., Heinz-Taheny, Kathleen, Ballard, Darryl W., Powell, Eric L., Dolled-Filhart, Marisa P., Christiansen, Jason, Gustavson, Mark, Biryukov, Jennifer, Virayah, Jagatheswari, Pratt, Susan E., Shepard, Robert L., Busbice, Sara C. Durland, Dantzig, Anne H.

Volltext

Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength von Smith, Rosamund C, Cramer, Martin S, Mitchell, Pamela J, Lucchesi, Jonathan, Ortega, Alicia M, Livingston, Eric W, Ballard, Darryl, Zhang, Ling, Hanson, Jeff, Barton, Kenneth, Berens, Shawn, Credille, Kelly M, Bateman, Ted A, Ferguson, Virginia L, Ma, Yanfei L, Stodieck, Louis S

Volltext

SMA-MAP: a plasma protein panel for spinal muscular atrophy von Kobayashi, Dione T, Shi, Jing, Stephen, Laurie, Ballard, Karri L, Dewey, Ruth, Mapes, James, Chung, Brett, McCarthy, Kathleen, Swoboda, Kathryn J, Crawford, Thomas O, Li, Rebecca, Plasterer, Thomas, Joyce, Cynthia, Chung, Wendy K, Kaufmann, Petra, Darras, Basil T, Finkel, Richard S, Sproule, Douglas M, Martens, William B, McDermott, Michael P, De Vivo, Darryl C, Walker, Michael G, Chen, Karen S

Volltext

Abstract B30: Altered response to the prodrug of gemcitabine LY2334737 by overexpression or knockdown of carboxylesterase 2 (CES2) von Durland-Busbice, Sara, Pratt, Susan E., Shepard, Robert L., Iversen, Philip W., Kays, Lisa, Ballard, Darryl, Heinz-Taheny, Kathleen, Dantzig, Anne H.

Volltext